Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Baxter

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,258,289

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,258,289
Title:Modulation of diacylglycerol acyltransferase 2 expression
Abstract: Compounds, compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding diacylglycerol acyltransferase 2. Methods of using these compounds for modulation of diacylglycerol acyltransferase 2 expression and for diagnosis and treatment of diseases and conditions associated with expression of diacylglycerol acyltransferase 2 are provided.
Inventor(s): Bhanot; Sanjay (Carlsbad, CA), Dobie; Kenneth W. (Del Mar, CA), Yu; Xing-Xian (San Diego, CA), Monia; Brett P. (Encinitas, CA)
Assignee: Isis Pharmaceuticals, Inc (Carlsbad, CA)
Application Number:12/748,281
Patent Claims:see list of patent claims

Details for Patent 8,258,289

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Isis Pharmaceuticals, Inc (Carlsbad, CA) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Isis Pharmaceuticals, Inc (Carlsbad, CA) ➤ Sign Up RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Isis Pharmaceuticals, Inc (Carlsbad, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,258,289

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2005019418 Jan 17, 2008
World Intellectual Property Organization (WIPO) 2005019418 Mar 03, 2005
World Intellectual Property Organization (WIPO) 2005019418 May 04, 2006
United States of America 2005043524 Feb 24, 2005
United States of America 2005272680 Dec 08, 2005
United States of America 2010311810 Dec 09, 2010
United States of America 2013123331 May 16, 2013
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Healthtrust
Queensland Health
Farmers Insurance
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.